Top-News
Gesundheitswesen Schweden

Vivesto AB News

Aktie
WKN:  509722 ISIN:  SE0000722365
0,0242 €
+0,00 €
0,00%
14.06.24 14:38:02
Handeln Depot/Watchlist
Aktienanzahl *
538,04 Mio.
Marktkapitalisierung *
13,02 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 05.04.2024

Ad-hocs

30.12.19 - GlobeNewswire
New number of shares and votes in Oasmia Pharmaceutical AB (publ)
The number of shares and votes in Oasmia Pharmaceutical AB (publ) has increased as a result of the preferential rights issue completed in December 2019. As a result of the ...
30.12.19 - GlobeNewswire
Oasmia Pharmaceutical AB (publ) Interim report for the period May 1 – October 31, 2019
EVENTS IN SECOND QUARTER Oasmia ADSs were delisted from NASDAQ in the US to reduce complexity and costs. Oasmia recruited two General Managers to its management ...
09.12.19 - GlobeNewswire
Final result of the rights issue in Oasmia
06.12.19 - GlobeNewswire
Oasmia’s rights issue has been oversubscribed
19.11.19 - GlobeNewswire
Oasmia publishes prospectus in connection with the rights issue of approximately SEK 399 million and updated information included in the prospectus
Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa, Switzerland, Singapore, the United States ...
11.11.19 - GlobeNewswire
Oasmia resolves on a rights issue of approximately SEK 399 million
Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa, Switzerland, Singapore, the United States ...
06.11.19 - GlobeNewswire
Extraordinary General Meeting in Oasmia Pharmaceutical AB on November 6, 2019
14.10.19 - GlobeNewswire
Notice of extraordinary general meeting in Oasmia Pharmaceutical AB
The shareholders of Oasmia Pharmaceutical AB (the “Company”) are hereby given notice of the extraordinary general meeting on Wednesday 6 November 2019, at 14:00 CET, at the ...
14.10.19 - GlobeNewswire
The Board of Directors in Oasmia proposes a rights issue of approximately SEK 400 million
The Board of Directors in Oasmia Pharmaceutical AB (”Oasmia” or the ”Company”) today announces a notice to an extra general meeting on 6 November 2019. It is proposed that the ...
26.09.19 - GlobeNewswire
Annual General Meeting in Oasmia Pharmaceutical AB on September 26, 2019
This is an unofficial in-house translation of the Swedish original. In case of differences the Swedish version shall prevail.
26.09.19 - GlobeNewswire
Oasmia Pharmaceutical AB (publ) Interim report for the period May 1 – July 31, 2019
EVENTS IN FIRST QUARTER
18.09.19 - GlobeNewswire
Oasmia publishes report on special investigation of liability issues conducted by audit firm Deloitte
In connection with Oasmia's year-end report in June 2019, the company's Board of Directors made a decision to engage a special examiner, audit firm Deloitte (Svante Forsberg ...
15.09.19 - GlobeNewswire
The Nomination Committee's proposal regarding Board of Directors and auditor of Oasmia Pharmaceutical AB for AGM 2019
Oasmia's Nomination Committee has informed the company of its proposal regarding Board of Directors and auditor ahead of the Annual General Meeting September 26, 2019.
05.09.19 - GlobeNewswire
Oasmia publishes its annual report and adjusts accounts due to write-downs - auditors do not recommend former board to be granted discharge from liability
Oasmia Pharmaceutical AB's annual report for the fiscal year 2018/2019 is now available on the company's website www.oasmia.com. Compared to the year-end report, which was ...
28.08.19 - GlobeNewswire
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
23.08.19 - GlobeNewswire
Oasmia ADSs delisted from NASDAQ in the US
20.08.19 - GlobeNewswire
Nomination committee in Oasmia for the 2019 AGM
In accordance with the decision at the Annual General Meeting of Oasmia Pharmaceutical AB on September 25, 2018, the two largest shareholders in terms of voting rights who ...
15.08.19 - GlobeNewswire
Oasmia postpones the release of the Q1 report to 26 September and adjusts its financial calendar
The Board of Oasmia has decided to postpone the release of the first quarter report 2019/2020 from 6 September 2019 to 26 September 2019 at 7.30 am CEST. The postponement ...
31.07.19 - GlobeNewswire
New number of shares and votes in Oasmia Pharmaceutical AB (publ)
05.07.19 - GlobeNewswire
Oasmia and Arwidsro have solved outstanding balances and Arwidsro increases its investment in Oasmia
Today an agreement has been made between Oasmia and its largest shareholder Arwidsro. The agreement is made to solve earlier unclear balances and to support the planned ...

Newssuche

Videos

13.06.24 0,00%
Technical Trading: Zukauf-​Chance bei Top-Trade, wenn
Sugar No.11 Long Typ: Turbo Open End WKN: VV50DP Hebel: 5 Laufzeit: OpenEnd Einstieg: prozyklisch ... Mehr »